Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation
Allergy · 2024
DOI: 10.1111/all.15967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Yujin Kwon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Natural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Plant Extracts, Disease Models, Animal, Forsythia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Science and Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a complex condition characterized by impaired epithelial barriers and dysregulated immune cells. In this study, we demonstrated Forsythia velutina Nakai extract (FVE) simultaneously inhibits basophils, macrophages, keratinocytes, and T cells that are closely interrelated in AD development.
Methods
We analyzed the effect of FVE on nitric oxide and reactive oxygen species (ROS) production in macrophages, basophil degranulation, T cell activation, and tight junctions in damaged keratinocytes. Expression of cell‐type‐specific inflammatory mediators was analyzed, and the underlying signaling pathways for anti‐inflammatory effects of FVE were investigated. The anti‐inflammatory effects of FVE were validated using a DNCB‐induced mouse model of AD. Anti‐inflammatory activity of compounds isolated from FVE was validated in each immune cell type.
Results
FVE downregulated the expression of inflammatory mediators and ROS production in macrophages through TLR4 and NRF2 pathways modulation. It significantly reduced basophil degranulation and expression of type 2 (T2) and pro‐inflammatory cytokines by perturbing FcεRI signaling. Forsythia velutina Nakai extract also robustly inhibited the expression of T2 cytokines in activated T cells. Furthermore, FVE upregulated the expression of tight junction molecules in damaged keratinocytes and downregulated leukocyte attractants, as well as IL‐33, an inducer of T2 inflammation. In the AD mouse model, FVE showed superior improvement in inflammatory cell infiltration and skin structure integrity compared to dexamethasone. Dimatairesinol, a lignan dimer, was identified as the most potent anti‐inflammatory FVE compound.
Conclusion
Forsythia velutina Nakai extract and its constituent compounds demonstrate promising efficacy as a therapeutic option for prolonged AD treatment by independently inhibiting various cell types associated with AD and disrupting the deleterious link between them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Korea.
- Division of Bio-Medical Science & Technology, University of Science and Technology (UST), Daejeon, Korea.
- Department of Marine Life Sciences, College of Life Science, Gangneung-Wonju National University, Gangneung, Korea.
- Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Korea.
- Department of Pharmacology, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Biology, Gangneung-Wonju National University, Gangneung, Korea.
ORCID-Profile: Yujin Kwon, Yoon Jin Kang, Jaeyoung Kwon, Su-Yeon Cho, Jiyoon Kim, Tam Thi Le, Hoseong Hwang, Barsha Deshar, Myungjun Kim, Ju Yeong Kim, Jae Hung Jung, Hyung-Sik Kim, Sang Hoon Jung, Hak Cheol Kwon, Won Kyu Kim
Förderung
- Korea Institute of Science and Technology
- National Research Foundation of Korea
Zitieren
APA
Kwon, Y., Kang, Y. J., Kwon, J., Cho, S. Y., Kim, J., Le, T. T., Hwang, H., Deshar, B., Kim, M., Kim, J. Y., Jung, J. H., Kim, H. S., Jung, S. H., Kwon, H. C., & Kim, W. K. (2024). Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation. Allergy. https://doi.org/10.1111/all.15967
Vancouver
Kwon Y, Kang YJ, Kwon J, Cho SY, Kim J, Le TT, et al. Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation. Allergy. 2024. doi:10.1111/all.15967
BibTeX
@article{Kwon2024,
author = {Kwon, Yujin and Kang, Yoon Jin and Kwon, Jaeyoung and Cho, Su-Yeon and Kim, Jiyoon and Le, Tam Thi and Hwang, Hoseong and Deshar, Barsha and Kim, Myungjun and Kim, Ju Yeong and Jung, Jae Hung and Kim, Hyung-Sik and Jung, Sang Hoon and Kwon, Hak Cheol and Kim, Won Kyu},
title = {Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.15967}
}
EUVIMED